COMMUNIQUÉS West-GlobeNewswire

Summary of capital reduction pursuant to Article 32 of the Danish Capital
29/03/2019
Please read the full announcement here Attachment 2019_05_Summary_of_capital_reduction_EN
Theratechnologies Appoints New Board Member
29/03/2019
MONTREAL, March 29, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced the appointment of Ms. Sheila M. Frame as a new independent member to its Board of Directors. “Sheila is [...]
Theratechnologies nomme un nouveau membre à son conseil d’administration
29/03/2019
MONTRÉAL, 29 mars 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Société) (TSX: TH) a annoncé aujourd’hui la nomination de Mme Sheila M. Frame à titre d’administratrice indépendante du conseil d’administration de la [...]
Reduction of common stock
29/03/2019
Please read the full announcement here Attachment 2019_04_Reduction_of_common_stock_EN
OpGen Announces Closing of Public Offering of Common Stock
29/03/2019
GAITHERSBURG, Md., March 29, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today the closing of its previously announced underwritten public offering of 9 million shares of its common stock at a public [...]
Auris Medical Announces Randomization of First Dose Cohort in AM-201 Phase 1b Proof-of-Concept Study
29/03/2019
Hamilton, Bermuda, March 29, 2019 - Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
Wildflower Featured in CannabisNewsAudio Publication on CBD Entering Mainstream Acceptance
29/03/2019
NEW YORK, March 29, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsAudio – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Publication titled, “ CBD Going Mainstream amid Flood [...]
Ritter Pharmaceuticals Reports Year End 2018 Financial Results and Provides Business Update
29/03/2019
LOS ANGELES, March 29, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat [...]
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
29/03/2019
NEW YORK, March 29, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “ Advanced Medical Technologies Provides Unprecedented [...]
Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million
29/03/2019
Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL, March 29, 2019 (GLOBE [...]
Eve & Co Announces Conversion Of Remaining Convertible Debentures, Strengthens Balance Sheet
29/03/2019
TORONTO, March 29, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQB: EEVVF) is pleased to announce that the remaining $4,000,000 principal amount of senior [...]
Assure Holdings Appoints Kelsie Jas as Director of Revenue Cycle Management
29/03/2019
DENVER, March 29, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Kelsie Jas as director of [...]
Statement re Cancellation
29/03/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION Certain information contained [...]
Passing of Genmab A/S’ Annual General Meeting
29/03/2019
Company Announcement At Genmab A/S’ Annual General Meeting held today March 29, 2019, the Annual Report for 2018 was approved Discharge was given to the Board of Directors and the Executive Management and the year’s [...]
Selecta Biosciences Initiates Head-to-Head Clinical Trial (COMPARE) of SEL-212 vs. KRYSTEXXA® in Patients with Chronic Refractory Gout and Strengthens Management Team
29/03/2019
-First patient enrolled in COMPARE trial evaluating efficacy and safety of SEL-212 v. KRYSTEXXA® in patients with chronic refractory gout -Strengthened management and clinical teams with the appointments of Elona Kogan [...]
World-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory Board
29/03/2019
SAN DIEGO, March 29, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, announced that Dr. Robert Langer, co-inventor of Daré‘s novel, segmented intravaginal ring (IVR) [...]
iTeos Therapeutics Announces Eight Data Presentations for A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR Annual Meeting 2019
29/03/2019
iTeos Therapeutics Announces Eight Data Presentations for A 2A Receptor Antagonist and Anti-TIGIT Antibody Programs at AACR Annual Meeting 2019 Gosselies, Belgium and Cambridge, MA – March 29, 2019 – iTeos Therapeutics [...]
EMA Grants PRIME Eligibility for KB103 to Treat Dystrophic Epidermolysis Bullosa
29/03/2019
First EMA PRIME eligibility for Krystal Biotech Eligibility based on positive primary analysis of clinical and non clinical data to date PRIME Designation allows for frequent and early interactions with the EMA aimed at [...]
Progressive Care Inc. Issues 2018 Annual Report Conference Call Highlights
29/03/2019
MIAMI, March 29, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today issued 2018 Annual Report Conference Call highlights. The Company [...]

Pages